[Federal Register Volume 73, Number 15 (Wednesday, January 23, 2008)]
[Notices]
[Page 3973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-1024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Assistant Secretary for Health have taken final action in 
the following case:
    Scott E. Monte, Huntington Memorial Hospital: Based on the findings 
of an investigation conducted by Huntington Memorial Hospital (HMH) and 
information obtained by the Office of Research Integrity (ORI) during 
its oversight review, the U.S. Public Health Service (PHS) found that 
Scott E. Monte, L.V.N., former Clinical Research Associate, HMH, 
engaged in scientific misconduct by knowingly and intentionally 
falsifying and fabricating clinical research records in HMH cancer 
prevention and treatment protocols supported by National Cancer 
Institute (NCI), National Institutes of Health (NIH), awards U10 
CA69651, U10 CA12027, U10 CA32012, and U10 CA86004.
    Specifically, Mr. Monte knowingly and intentionally:
    (1) Entered falsified and fabricated laboratory data or physical 
examination results on five (5) research protocol case report forms 
(CRFs);
    (2) Falsified a gynecological examination report in a physician's 
progress note and entered the falsified document in the patient's 
research chart; and
    (3) Fabricated progress notes for four patients and a case report 
form for one of these patients.
    ORI has implemented the following administrative actions for a 
period of three (3) years, beginning on January 7, 2008:
    (1) Dr. Monte is debarred from any contracting or subcontracting 
with any agency of the United States Government and from eligibility or 
involvement in nonprocurement programs of the United States Government 
pursuant to HHS' implementation of the OMB Guidelines to Agencies on 
Governmentwide Debarment and Suspension at 2 CFR Part 376; and
    (2) Dr. Monte is prohibited from serving in any advisory capacity 
to PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
 [FR Doc. E8-1024 Filed 1-22-08; 8:45 am]
BILLING CODE 4150-31-P